-
In a national study, menstrual disorders accounted for 19.1% of 20.1 million physician office visits for gynecologic conditions over two years.
-
More women are now choosing long-acting reversible contraceptive (LARC) methods, such as intrauterine devices (IUDs) and the subdermal contraceptive implant. The number of women using LARC methods rose from 2.4% in 2002 to 8.5% in 2009.
-
Make the first reproductive health visit for a young teen a successful one by using the HEEADSSS (Home environment, Education and employment, Eating, peer-related Activities, Drugs, Sexuality, Suicide/depression, and Safety from injury and violence) method of interviewing in performing a psychosocial review of systems.
-
Just-released results from international trials indicate a potential vaccine, designed to protect against nine HPV strains, might be the next step in cervical cancer protection. In the pivotal Phase III efficacy study, the investigational 9-valent HPV vaccine prevented approximately 97% of cervical, vaginal, and vulvar pre-cancers caused by HPV types 31, 33, 45, 52, and 58.
-
-
As a healthcare provider, there are several things you can do to help women lower their risks for gynecologic cancer.
-
-
FHI 360 has launched its Contraceptive Technology Innovation Initiative to develop innovative, long-acting contraceptives.
-
Women seeking emergency contraception (EC) are at high risk of unintended pregnancy.
-
Some 776,000 U.S. residents incur new genital herpes infections annually. There is no cure. Initial, positive results are reported for a therapeutic vaccine candidate for treating genital herpes.
